Disorders of the Adrenal Cortex Hyperaldosteronism Hyperaldosteronism may be secondary to stimulation of the reninangiotensin system from renal artery stenosis and to lowflow states such as congestive heart ID: 751670
Download Presentation The PPT/PDF document "Adrenal and retropetionium" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Adrenal and retropetioniumSlide2
Disorders of the Adrenal Cortex
Hyperaldosteronism:
Hyperaldosteronism
may be
secondary to stimulation
of the renin-angiotensin system from renal
artery stenosis
and to low-flow states such as congestive heart
failure and
cirrhosis.
Primary hyperaldosteronism
results from autonomous
aldosterone secretion
,
leads
to suppression of renin secretion
. Hypokalemia.
Most cases result from a solitary
functioning adrenal
adenoma (∼70%) and idiopathic bilateral
hyperplasia (30
%). Adrenocortical carcinoma and
glucocorticoid-suppressible hyperaldosteronism
are
rare.
Symptoms and
Signs:
hypertension
,
muscle weakness, polydipsia, polyuria,
nocturia
, headaches
, and fatigue. Weakness and fatigue are related to
the presence
of hypokalemia.
Diagnostic Studies
Laboratory
Studies
Hypokalemia.
plasma aldosterone concentration–to–plasma
renin activity
ratio of 1:25 to 30 is strongly suggestive of the diagnosis
.
Radiologic Studies.
CT scans with 0.5-cm cuts in the
adrenal area
can localize
aldosteronomas
with a sensitivity of 90
%.
MRI scans are less
sensitive but
more
specific.
Selective venous catheterization
and adrenal
vein sampling for
aldosterone.
Scintigraphy with 131I-6
β-
iodomethyl
noriodocholesterol
(
NP-59) also
may be used for the same purpose.
Treatment:
Unilateral tumors producing aldosterone are best managed
by adrenalectomy.
For the other
patients, medical
therapy with spironolactone,
amiloride
, or
triamterene is
the mainstay of management.Slide3
Cushing’s Syndrome.
Cushing described patients with a
peculiar fat
deposition, amenorrhea, impotence (in men
), hirsutism, purple
striae
, hypertension, diabetes, and other features that
constitute the syndrome.
Today, the term
Cushing’s syndrome
refers
to a
complex of symptoms and signs resulting from
hypersecretion of
cortisol regardless of etiology.
In contrast,
Cushing’s
disease
refers
to a pituitary tumor, usually an adenoma, which leads
to bilateral
adrenal hyperplasia and
hypercortisolism
.
Although most individuals have sporadic
disease.
Cushing’s syndrome
may be found in MEN1
families.Slide4
Etiology
of Cushing’s syndrome
ACTH-dependent (70%)
• Pituitary adenoma or Cushing’s disease (∼70%)
• Ectopic ACTH
production
a
(∼10%)
• Ectopic CRH production (<1%)
ACTH-independent (20%–30%)
• Adrenal adenoma (10%–15%)
• Adrenal carcinoma (5%–10%)
• Adrenal hyperplasia—pigmented
micronodular
cortical hyperplasia
or gastric inhibitory
peptide-sensitive
macronodular
hyperplasia (5%)
Other
• Pseudo-Cushing’s syndrome
• Iatrogenic—exogenous administration of steroids
_________________________________
a
From
small cell lung tumors, pancreatic islet cell tumors,
medullary thyroid
cancers,
pheochromocytomas
, and carcinoid tumors of the
lung, thymus
, gut, pancreas, and
ovary.
ACTH
= adrenocorticotropic hormone; CRH =
corticotrophin-releasing hormone
.Slide5
Patients with major
depression, alcoholism
, pregnancy, chronic renal failure, or stress
also may
have elevated cortisol levels and symptoms
o
hypercortisolism
. However
, these manifestations resolve with treatment
of the
underlying disorder, and these patients are deemed to
have pseudo-Cushing’s
syndrome.Slide6
Symptoms and
Signs ;
Progressive
truncal obesity is
the most
common symptom, occurring in up to 95% of patients.
System
Manifestation
General
Weight gain—central obesity,
buffalo hump, supraclavicular
fat pads
Integumentary
Hirsutism, plethora, purple
striae
, acne, ecchymosis
Cardiovascular
Hypertension
Musculoskeletal
Generalized weakness,
osteopenia
Neuropsychiatric
Emotional lability, psychosis,
depression
Metabolic
Diabetes or glucose
intolerance, hyperlipidemia
Renal
Polyuria, renal stones
Gonadal
Impotence, decreased libido,
menstrual irregularitiesSlide7
Diagnostic
Tests:
confirm
the presence of Cushing’s syndrome and
to determine
its
etiology.
characterized
by elevated
glucocorticoid levels that are not suppressible by
exogenous hormone
administration and loss of diurnal variation.Radiologic Studies:
CT and MRI
scans.
Radioscintigraphic
imaging.
Treatment:
Laparoscopic adrenalectomy is the treatment
of choice
for patients with
adrenal adenomas
. Open
adrenalectomy is
reserved for large tumors (≥6 cm) or those suspected to
be adrenocortical
cancers. Bilateral adrenalectomy is curative
for primary
adrenal
hyperplasia. Slide8
The treatment of choice in Cushing’s disease is
transsphenoidal
excision
of the pituitary
adenoma.
Pituitary irradiation has been used for
patients with
persistent or recurrent disease after surgery.
Patients with ectopic ACTH production are best
managed by
treating the primary tumor.Slide9
Adrenocortical Cancer.
Adrenal carcinomas are rare
neoplasms with
a worldwide incidence of two per 1 million.
The majority
are
sporadic,
but adrenocortical carcinomas
also occur
in
(Li-
Fraumeni syndrome
) and
MENIN
(multiple endocrine neoplasia type 1
).
Symptoms and Signs
Approximately 50% of
adrenocortical cancers
are
nonfunctioning.
The remaining secrete
cortisol
(30
%), androgens (20%), estrogens (10%), aldosterone (2
%),
or
multiple hormones (35%).
Diagnostic
Tests:
measurement of serum electrolyte levels to rule out
hypokalemia, urinary
catecholamines
to rule out
pheochromocytomas
, an
overnight 1-mg dexamethasone suppression test, and
a 24-hour
urine collection for cortisol and 17-ketosteroids to
rule out
Cushing’s syndrome.
CT and MRI
scans.
FDGPET
or
PET-CT scans may have some utility in
distinguishing benign
from malignant
lesions.Slide10
Treatment:
The most important predictor of survival in
patients with
adrenal cancer is the adequacy of resection.Slide11
Sex Steroid
Excess:
Adrenal adenomas or
carcinomas that
secrete adrenal androgens
lead to
virilizing
syndromes. Although
women
with
virilizing tumors develop hirsutism,amenorrhea, infertility, and other signs of masculinization,
suchas
increased muscle mass, deepened voice, and temporal
balding,
men
with these tumors are more difficult to diagnose
and, hence
, usually present with disease in advanced stages.
Children with
virilizing
tumors
have accelerated growth,
premature development
of facial and pubic hair, acne, genital
enlargement, and
deepening of their
voice.
Feminizing
adrenal tumors
are
less common
and occur in
men
in the third to fifth decades of
life. These
tumors lead to gynecomastia, impotence, and
testicular atrophy
.
Women
with these tumors develop irregular
menses or
dysfunctional uterine bleeding. Vaginal bleeding may
occur I postmenopausal
women. Girls with these tumors
experience precocious
puberty with breast enlargement and early menarche.
Diagnostic
Tests: lab teste.
Eg
androgen
precursor
,
plasma or urine as
17-ketosteroids, etc.Slide12
Treatment
Virilizing
and feminizing tumors are treated
by
adrenalectomy
. Malignancy
is difficult to diagnose histologically
but is
suggested by the presence of local invasion, recurrence,
or distal
metastases.
Adrenolytic drugs such as mitotane,
aminoglutethimide
, and
ketoconazole may be useful in controlling
symptoms in
patients with metastatic disease.Slide13
Disorders of the Adrenal Medulla
Pheochromocytomas
:
Pheochromocytomas
are
rare
tumors
with
prevalence rates ranging from 0.3% to 0.95% in
autopsy series
and approximately 1.9% in series using
biochemical screening
. They
can occur at any age
, with a
peak incidence in
the fourth
and fifth decades of life
, and have no gender predilection.
Extra-adrenal tumors, also called functional
paragangliomas
.
Pheochromocytomas
often
are
called the
10 percent tumor
because 10
% are bilateral, 10% are malignant, 10% occur in
pediatricpatients
, 10% are extra-adrenal, and 10% are familial.
Pheochromocytomas
occur in families with MEN2A
and MEN2B
in approximately 50% of patients
.
MEN1
syndrome.
Symptoms and
Signs:
Headache, palpitations, and
diaphoresis constitute
the “classic triad”
of
pheochromocytomas
.
Cardiovascular
complications,.
The
most common clinical sign is hypertension.
may be paroxysmal
with intervening
normotension
, sustained with paroxysms
or sustained hypertension alone.
Sudden
death may occur
in patients
with undiagnosed tumors who undergo other
surgeries or
biopsy.Slide14
Diagnostic Tests
Biochemical
Studies:
24-hour urine samples for
catecholamines
and their
metabolitesas
well as by determining plasma
metanephrine
levels.VMA measurements are slightly less sensitive and specific.Extraadrenal
tumors
secrete norepinephrine, whereas epinephrine
is the
main hormone secreted from adrenal
pheochromocytomas
.
Radiologic
Studies:
o
localize tumors
and to assess the extent of spread once
th
diagnosis has been
made with biochemical tests.
CT
scans, MRI scans,
Metaiodobenzylguanidine
(
MIBG) is
taken up and concentrated by vesicles in the adrenal
medullar cells
because its structure is similar to norepinephrine
.
131I-radiolabeled
MIBG
especially those in ectopic positions.Slide15
Treatment:
The medical management of
pheochromocytomas
is aimed
chiefly at blood pressure control and volume repletion.
long-acting α-blockers such as
phenoxybenzamine
are
started 1 to 3 weeks before surgery
β-Blockers such as propranolol often need to be added preoperatively in patients
who have
persistent tachycardia and arrhythmias
β-
Blockers
should only
be instituted after adequate α-blockade and hydration
to avoid
the effects of unopposed α stimulation (i.e.,
hypertensive
crisis and congestive heart failure
).
Adrenalectomy is the treatment of choice for patients
with
pheochromocytoma
.
to resect
the tumor
completely with minimal tumor manipulation or
rupture of
the tumor capsule.Slide16
Hereditary
Pheochromocytomas
Malignant
Pheochromocytomas
:
Malignancy usually
is diagnosed
when there is evidence of invasion into
surrounding structures
or distant metastases.
The Adrenal
Incidentaloma
Adrenal
lesions discovered during imaging performed for
unrelate
reasons
are referred to as
incidentalomas
.
Adrenal
Insufficiency:
may be primary, resulting from
adrenal disease
, or secondary, due to a deficiency of
ACTH. Treatment
must be initiated based on clinical
suspicion alone
, even before test results are obtained, or the
patient is
unlikely to survive.Slide17
multiple endocrine neoplasia type I (
MEN I
), which consists of parathyroid, pituitary, and pancreatic (
or duodenal
) tumors.
MEN2A:
MTC,
pheochromocytoma
,
primary hyperparathyroidism.
MEN2A is associated with medullary thyroid carcinoma
and pheochromocytoma or parathyroid adenoma
MEN2B:
MTC,
pheochromocytoma
,
Marfanoid
habitus
,
mucocutaneous
ganglioneuromatosis
MEN2B is associated with medullary
thyroid carcinoma
,
marfanoid
habitus, mucosal neuromas,
and
ganglioneuromatosis
.Slide18
RETROPERITONEUM
Surgical
Anatomy:
The retroperitoneum is defined as the space between the
posterior envelopment
of the peritoneum and the posterior body
wall.
The retroperitoneal space is bounded superiorly
bythe
diaphragm, posteriorly by the spinal column and
iliopsoas muscles, and inferiorly by the
levator
ani
muscles
.
Retroperitoneal
Infections:
Retrocecal
appendicitis, contained
perforation of duodenal ulcers,
iatrogenic perforation
with esophagogastroduodenoscopy or
endoscopic retrograde
cholangiopancreatography, and complicated
pancreatitis may
all lead to retroperitoneal infection with or
without abscess
formation.Slide19
The site of pain may
be variable
and can include the back, pelvis, or thighs.
Erythema may
be observed around the umbilicus or flank.
The
diagnosis is
best established by
CT.
Management
includes identification
and treatment of the underlying condition, intravenous antibiotics
, and drainage of all well-defined collections.Slide20
Retroperitoneal
Fibrosis:
Retroperitoneal fibrosis is a class of disorders characterized
by
hyperproliferation
of fibrous tissue in
the retroperitoneum
.
may be a primary disorder as in idiopathic retroperitoneal
fibrosis, also
known as Ormond’s disease, or a secondary reaction
to an
inciting inflammatory process, malignancy, or medication.
Presenting symptoms depend on the structure or
structures affected
by the fibrotic process. Initially, patients complain
of the
insidious onset of dull, poorly localized abdominal
pain. Sudden-onset
or severe abdominal pain may signify acute
mesenteric ischemia
. Other symptoms of retroperitoneal
fibrosis may
include unilateral leg swelling, intermittent
claudication, oliguria
, hematuria, or dysuria.Slide21
findings on
physical examination
vary with the retroperitoneal structure
involved. Consequently
, findings may include hypertension, the
palpation of
an abdominal or flank mass, lower-extremity edema (
unilateral or
bilateral), or diminished lower-extremity pulses (
unilateral or
bilateral).
Laboratory evaluation and Many imaging modalities have been
used.
Once malignancy, drug-induced, and infectious
etiologies are
ruled out, treatment of
the retroperitoneal
fibrotic
process is
instituted. Corticosteroids, with or without surgery, are
the mainstay
of medical therapy. Surgical treatment consists
primarily of
ureterolysis or ureteral stenting and is required in
patients who
present with significant
hydronephrosis
.
Endovascular interventions for
iliocaval
occlusion
Cyclosporin
, tamoxifen
, and azathioprine have also been used to
treat patients
who respond poorly to corticosteroids.Slide22Slide23
The outermost layer, the
zona glomerulosa
is the main site for production of
aldosterone
.
Situated between
the glomerulosa and
reticularis the
zona
fasciculata
is responsible for
prdoucing
glucocorticoids
. Such as
11deoxycorticosterone
,
corticosterone
, and
cortisol
The inner most cortical
layer, the
zona reticularis
produces
androgens
,mainly
dehydroepiandrosterone
(DHEA),
DHEA sulfate
(DHEA-S), and
androstenedione
(the precursor to
testosterone
) in humans.Slide24
Adrenal
Physiology
Cholesterol, derived from the plasma or synthesized in the
adrenal, is
the common precursor of all steroid hormones
derived from
the adrenal cortex
.
Mineralocorticoids:
aldosterone, 11-deoxycorticosterone (DOC),
and cortisol
.
Aldosterone secretion is regulated
primarily by
the renin-angiotensin
system.
Decreased renal blood
flow, decreased
plasma sodium, and increased sympathetic
tone all
stimulate the release of renin from juxtaglomerular cells.
Glucocorticoids:
cortisol, the major
adrenal glucocorticoid
, is regulated by ACTH secreted by the
anterior pituitary
, which, in turn, is under the control of
corticotrophinreleasing
hormone
(CRH) secreted by the hypothalamusSlide25
Functions of glucocorticoid hormones
Function/System
Effects
Glucose metabolism
Increased hepatic
glycoge
deposition, gluconeogenesis,
decreased muscle
glucos
uptake and metabolism
Protein metabolism
Decreased muscle protein synthesis, increased Catabolism
Fat metabolism
Increased lipolysis in adipose tissue
Connective tissue
Inhibition of fibroblasts, loss of collagen, thinning of skin,
striae
formation
Skeletal system
Inhibition of bone formation, increased osteoclast activity,
potentiate the action of PTH
Immune system
Increases circulation of
polymorphonuclear
cells; decreases numbers of lymphocytes, monocytes, and eosinophils; reduces migration of inflammatory cells to sites of injury
Cardiovascular system
Increases cardiac output and peripheral vascular tone
Renal system
Sodium retention, hypokalemia, hypertension via mineralocorticoid effect, increased glomerular filtration via glucocorticoid Effects
Endocrine system
Inhibits TSH synthesis and release, decreased TBG
levels, decreased conversion of T4 to T3